EP Patent

EP0740581B1 — Yttria particulate material

Assigned to Sirtex Medical Pty Ltd · Expires 2004-11-10 · 22y expired

What this patent protects

A particulate material which comprises hollow or cup-shaped ceramic microspheres having a diameter in the range of from 5 to 200 microns. The material may comprise a beta- or gamma-emitting radionuclide and be used in selective internal radiation therapy (SIRT) of various forms o…

USPTO Abstract

A particulate material which comprises hollow or cup-shaped ceramic microspheres having a diameter in the range of from 5 to 200 microns. The material may comprise a beta- or gamma-emitting radionuclide and be used in selective internal radiation therapy (SIRT) of various forms of cancer and tumours.

Drugs covered by this patent

Patent Metadata

Patent number
EP0740581B1
Jurisdiction
EP
Classification
Expires
2004-11-10
Drug substance claim
No
Drug product claim
No
Assignee
Sirtex Medical Pty Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.